logo
calendar30 Yanvar 2021
view34
Main language:Russian

OPTIMIZATION OF THE ENDOSCOPIC STOP OF BLEEDING FROM VARICOSE-EXTENDED VESES OF THE ESOPHAGUS ON THE BACKGROUND OF PHARMACOTHERAPY

Field of Science:
pdf

61b9b4aff17ab.pdf

PDF

ARTICLE ANNOTATION

quote
The paper presents the results of examination and surgical treatment of 27 patients with portal hypertension syndrome, complicated by bleeding from varicose veins of the esophagus and stomach, with the inclusion of x-ray surgical interventions in the complex of hemostatic measures. The rational use of the developed diagnostic algorithm in a complex of hemostatic methods of treating patients with portal hypertension complicated by profuse bleeding from the varicose veins of the esophagus and stomach made it possible to reduce the recurrence rate of bleeding from 47.2% to 31.4%, and the overall mortality rate from 72.2% to 22 ,1%.

AUTHORS

D.Xojimetov

Андижанский Государственный медицинский институт

M.Nishonov

Андижанский Государственный медицинский институт

A.Xabubullayev

Андижанский Государственный медицинский институт

M.Aliboyev

Андижанский Государственный медицинский институт

Tags

# surgical treatment# хирургическое лечение# portal hypertension# портальная гипертензия# кровотечение из варикознорасшире# varicose bleeding veins of the e# Portal gipertenziya# varikoz qon ketishi# qizilo'ngach va oshqozon tomirla# jarrohlik davolash

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

References

1. 1.Figueiredo A, Romero-Bermejo F, Perdigoto R, Marcelino P. The EndOrgan Impairment in Liver Cirrhosis: Appointments for Critical Care. Critical Care Research and Practice. 2012.

2. Wiegand J, Berg T: The etiology, diagnosis and prevention of liver cirrhosis-part 1 of a series on liver cirrhosis. Dtsch. Arztebl. Int. 2013; 110: 6: 85–91.

3. Шерцингер А.Г., Жигалова С.Б., Мелкумов А.Б., Манукьян В.Г. Варикозное расширение вен желудка у больных портальной гипертензией: диагностика и лечение. Анн. хирург. гепатологии. 2010; XV: 3: 84-94.

4. Назыров Ф.Г., Девятов А.В., Бабаджанов А.Х. Сводный анализ результатов и конкурентные перспективы портосистемного шунтирования у больных циррозом печени. Анн. хирург. гепатологии. 2015; XV: 3: 36-41.

5. Stine JG, Shah PM, Cornella SL, Rudnick SR, Ghabril MS, Stukenborg GJ, Northup PG. Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis. World J Hepatol. 2015; 28; 7(27): 2774-2780.

6. Назыров Ф.Г., Соколова А.С., Девятов А.В., Саяпин С.Н. Анализ состояния и перспективы развития трансформируемых зондов для остановки кровотечений из варикозно-расширенных вен пищевода. Хирургия. 2010; 12: 58-64.

7. Souk K, Al-Badri M, Azar ST. The Safety and Benefit of Statins in Liver Cirrhosis: a Review. Exp Clin Endocrinol Diabetes. 2015; 123(10): 577-80. 8. Romcea AA, Tanţău M, Seicean A, Pascu O. The etiology of upper gastrointestinal bleeding in cirrhotic patients. Clujul Med. 2013; 86(1): 21-3.

8. Williams MJ, Hayes P. Improving the management of gastrointestinal bleeding in patients with cirrhosis. Expert Rev Gastroenterol Hepatol. 2015; 7: 1-11.

9. Garcia-Tsao G., Lim J. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program. American Journal of Gastroenterology. 2009; 104: 7: 1802–1829

10. Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P, Gasparini D, Miotto D, Simioni P, Tsochatzis E, A Burroughs K. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012; 32(6): 919-27.

11. Escorsell À, Pavel O, Cárdenas A, Morillas R, Llop E, Villanueva C, Garcia-Pagán JC, Bosch J; Variceal Bleeding Study Group. Esophageal balloon tamponade Vs esophageal stent in controlling acute refractory variceal bleeding: A multicenter RCT. Hepatology. 2015; 24.